Newsletter
Interferon β1a for ARDS, Microaxial LVAD vs IABP for Cardiogenic Shock, Abbreviated Breast MRI vs DBT for Breast Cancer Screening, Screening for Cognitive Impairment, and more

JAMA Editor’s Summary

Interferon β1a for ARDS, Microaxial LVAD vs IABP for Cardiogenic Shock, Abbreviated Breast MRI vs DBT for Breast Cancer Screening, Screening for Cognitive Impairment, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the
February 25, 2020

Interferon β1a for ARDS, Microaxial LVAD vs IABP for Cardiogenic Shock, Abbreviated Breast MRI vs DBT for Breast Cancer Screening, Screening for Cognitive Impairment, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 25, 2020 issue

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
What Will Variant Sigma Look Like? with Michael T. Osterholm, Ph.D., Regents Professor, Division of Environmental Health Science; Director, Center for Infectious Disease Research and Policy (CIDRAP) University of Minnesota